MicroRNA Expression in Human Blood Serum and Vitreous Body | NCT01462734

Studies
MicroRNA Expression in Human Blood Serum and Vitreous Body

NCT01462734

Sponsor

Kyorin University

Status

Completed

Last Update Posted

Apr 1, 2015Estimated

Enrollment

8Actual

Phase

Not provided

Conditions

MicroRNA Expression Profile in Human Vitreous

Interventions

human vitreous and blood serum sampling, PCR

Countries

Japan

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Mar 2015

Overall Recruitment Status or Expanded Access Status

Completed

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Oct 2011

Primary Completion Date

Dec 2014Actual

Completion Date

Not provided

First Submitted Date

Oct 26, 2011

First Submission Date that Met QC Criteria

Oct 27, 2011

First Posted Date

Oct 31, 2011Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Mar 31, 2015

Last Update Posted Date

Apr 1, 2015Estimated

Oversight Module

Has Data Monitoring Committee (DMC)

Is FDA Regulated Drug

Not provided

Is FDA Regulated Device

Not provided

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

MicroRNAs are important regulators of many cellular functions but their expression profile in human vitreous is still unclear. Aim of this study is to investigate microRNA expression profile by PCR in human vitreous of macula hole patients which is suggested to be similar to that of healthy patients.

Detailed Description

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

Retention

Enrollment

8Actual

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
human vitreous, human blood serum, PCR		Vitreous and bloodserum samples from macula hole patients without previous ocular or systemic disease	Procedure: human vitreous and blood serum sampling, PCR

Interventions

Name	Type	Description	Arm Group Labels	Other Names
human vitreous and blood serum sampling, PCR	Procedure	1ml of human vitreous and 3ml of human blood serum	human vitreous, human blood serum, PCR

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
MicroRNA expression profile in human vitreous investigated by PCR		1month

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Female macula hole patients without previous ocular or systemic disease.

Accepts Healthy Volunteers

Sex

Female

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

Not provided

Maximum Age

Not provided

Standard Ages

ChildAdultOlder Adult

Study Population

Female pateints undergoing vitrectomy for macula hole without previous ocular or systemic disease

Sampling Method

Non-Probability Sample

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Not provided

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Kyorin University School Of Medicine		Tokyo	Mitakasi Sinkawa6-20-2	181-8611	Japan

Intervention Browse Module

MeSH Terms

ID	Term
D016133	Polymerase Chain Reaction

Ancestor Terms

ID	Term
D021141	Nucleic Acid Amplification Techniques
D005821	Genetic Techniques
D008919	Investigative Techniques

Browse Leaves

Not provided

Browse Branches

Not provided